BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 10523063)

  • 1. Anxiety with depression: a treatment need.
    Rouillon F
    Eur Neuropsychopharmacol; 1999 Jul; 9 Suppl 3():S87-92. PubMed ID: 10523063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression with anxiety and atypical depression.
    Liebowitz MR
    J Clin Psychiatry; 1993 Feb; 54 Suppl():10-4; discussion 15. PubMed ID: 8444829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitors in mixed anxiety-depression.
    Berk M
    Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S41-5. PubMed ID: 11110018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of patients with depression associated with anxiety symptoms.
    Nutt D
    J Clin Psychiatry; 1997; 58 Suppl 8():11-6. PubMed ID: 9236730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of antidepressants currently used to treat anxiety disorders.
    Feighner JP
    J Clin Psychiatry; 1999; 60 Suppl 22():18-22. PubMed ID: 10634351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating comorbid depression and anxiety.
    Kuzel RJ
    J Fam Pract; 1996 Dec; 43(6 Suppl):S45-53. PubMed ID: 8969712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in total medical costs across the SSRIs for the treatment of depression and anxiety.
    Sheehan DV; Eaddy MT; Shah MB; Mauch RP
    Am J Manag Care; 2005 Oct; 11(12 Suppl):S354-61. PubMed ID: 16236017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spotlight on paroxetine in psychiatric disorders in adults.
    Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
    CNS Drugs; 2002; 16(6):425-34. PubMed ID: 12027788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of depression with comorbid anxiety disorders: differential efficacy of paroxetine versus moclobemide.
    Pini S; Amador XF; Dell'Osso L; Baldini Rossi N; Cassano P; Savino M; Cassano GB
    Int Clin Psychopharmacol; 2003 Jan; 18(1):15-21. PubMed ID: 12490770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Range of activity of anxiolytic and antidepressant drugs].
    Linkowski P
    Rev Med Brux; 1996 Sep; 17(4):220-3. PubMed ID: 8927849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
    Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Care of depressed patients with anxiety symptoms.
    Nutt DJ
    J Clin Psychiatry; 1999; 60 Suppl 17():23-7; discussion 46-8. PubMed ID: 10446738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbid depression and anxiety spectrum disorders.
    Gorman JM
    Depress Anxiety; 1996-1997; 4(4):160-8. PubMed ID: 9166648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?
    Cardamone L; Salzberg MR; O'Brien TJ; Jones NC
    Br J Pharmacol; 2013 Apr; 168(7):1531-54. PubMed ID: 23146067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are SSRIs really more effective for anxious depression?
    Panzer MJ
    Ann Clin Psychiatry; 2005; 17(1):23-9. PubMed ID: 15941028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding and treating depression in anxious patients.
    Dubovsky SL
    J Clin Psychiatry; 1990 Oct; 51 Suppl():3-8; discussion 14-7. PubMed ID: 1976623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbid anxiety and depression.
    Pollack MH
    J Clin Psychiatry; 2005; 66 Suppl 8():22-9. PubMed ID: 16336033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: Is it worth investigating?
    Ribot R; Ouyang B; Kanner AM
    Epilepsy Behav; 2017 May; 70(Pt A):5-9. PubMed ID: 28407526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to paroxetine CR compared with paroxetine IR in a Medicare-eligible population with anxiety disorders.
    Keene MS; Eaddy MT; Nelson WW; Sarnes MW
    Am J Manag Care; 2005 Oct; 11(12 Suppl):S362-9. PubMed ID: 16236018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of new antidepressants in the treatment of anxiety/depressive disorders.
    Boerner RJ; Möller HJ
    Pharmacopsychiatry; 1999 Jul; 32(4):119-26. PubMed ID: 10505481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.